NUTX — Nutex Health Share Price
- $33.88m
- $276.58m
- $247.65m
- 42
- 92
- 14
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.44 | ||
Price to Tang. Book | 1.08 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.11 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -7.51% | ||
Return on Equity | -52.69% | ||
Operating Margin | -10% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1.37 | 1.59 | 18.79 | 219.29 | 247.65 | 286.2 | 333.6 | 428.22% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Nutex Health Inc. is a healthcare management and operations company. The Company operates through three segments: The Hospital division, The Population Health Management (PHM) division and The Real Estate division. The Hospital division develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs) providing comprehensive and high-quality 24/7 care. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). The Real Estate division owns the land and hospital buildings which are leased to its hospital entities. The Company also provides limited services to one health maintenance organization (HMO) and two other IPAs in Southern and Northern California. The Company's cloud-based technology platform aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- April 13th, 2000
- Public Since
- March 18th, 2011
- No. of Shareholders
- 870
- No. of Employees
- 800
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 49,719,375
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 6030 S. Rice Ave., Suite C, HOUSTON, 77081
- Web
- https://www.nutexhealth.com/
- Phone
- +1 7136600557
- Contact
- Jennifer Rodriguez
- Auditors
- Marcum LLP
Upcoming Events for NUTX
Q2 2024 Nutex Health Inc Earnings Release
Q3 2024 Nutex Health Inc Earnings Release
Similar to NUTX
23andMe Holding Co.
NASDAQ Capital Market
ADVANCED BIOMED
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Assure Holdings
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
FAQ
As of Today at 16:26 UTC, shares in Nutex Health are trading at $0.56. This share price information is delayed by 15 minutes.
Shares in Nutex Health last closed at $0.56 and the price had moved by -92.72% over the past 365 days. In terms of relative price strength the Nutex Health share price has underperformed the S&P500 Index by -94.21% over the past year.
The overall consensus recommendation for Nutex Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Nutex Health does not currently pay a dividend.
Nutex Health does not currently pay a dividend.
Nutex Health does not currently pay a dividend.
To buy shares in Nutex Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.56, shares in Nutex Health had a market capitalisation of $27.83m.
Here are the trading details for Nutex Health:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: NUTX
Based on an overall assessment of its quality, value and momentum Nutex Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Nutex Health is $5.00. That is 793.18% above the last closing price of $0.56.
Analysts covering Nutex Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.22 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nutex Health. Over the past six months, its share price has underperformed the S&P500 Index by -84.47%.
As of the last closing price of $0.56, shares in Nutex Health were trading -73.43% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nutex Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.56.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nutex Health's directors